MOH · Insider Trading
Molina Healthcare, Inc.
Every open-market purchase and sale reported by MOH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Francis S Soistman Jr | Director | A | +304 | +$54.98K |
| 2026-10-02 | Stephen H Lockhart | Director | A | +304 | +$54.98K |
| 2026-10-02 | Steven J Orlando | Director | A | +304 | +$54.98K |
| 2026-10-02 | Dale B Wolf | Director | A | +304 | +$54.98K |
| 2026-10-02 | Leo P Grohowski | Director | A | +304 | +$54.98K |
| 2026-10-02 | Richard C Zoretic | Director | A | +304 | +$54.98K |
| 2026-10-02 | Barbara L Brasier | Director | A | +304 | +$54.98K |
| 2026-10-02 | Richard M Schapiro | Director | A | +304 | +$54.98K |
| 2026-10-02 | Ronna Romney | Director | A | +304 | +$54.98K |
| 2026-07-02 | Leo P Grohowski | Director | A | +237 | +$55.11K |
| 2026-07-02 | Jeff D. Barlow | Chief Legal Officer | A | +138 | +$20.36K |
| 2026-07-02 | James Woys | Chief Operating Officer | A | +144 | +$21.24K |
| 2026-07-02 | Ronna Romney | Director | A | +237 | +$55.11K |
| 2026-07-02 | Steven J Orlando | Director | A | +237 | +$55.11K |
| 2026-07-02 | Barbara L Brasier | Director | A | +237 | +$55.11K |
| 2026-07-02 | Richard M Schapiro | Director | A | +237 | +$55.11K |
| 2026-07-02 | Richard C Zoretic | Director | A | +237 | +$55.11K |
| 2026-07-02 | Dale B Wolf | Director | A | +237 | +$55.11K |
| 2026-07-02 | Debra Bacon | EVP, Medicaid | MIXED | −160 | −$39.16K |
| 2026-07-02 | Stephen H Lockhart | Director | A | +237 | +$55.11K |
| 2026-07-02 | Francis S Soistman Jr | Director | A | +237 | +$55.11K |
| 2026-05-15 | Maurice Hebert | Chief Accounting Officer | Sell | −600 | −$114.93K |
| 2026-05-13 | Jeff D. Barlow | Chief Legal Officer | Sell | −17,811 | −$3.31M |
| 2026-05-08 | Francis S Soistman Jr | Director | A | +170 | +$33.56K |
| 2026-04-02 | Ronna Romney | Director | A | +405 | +$55.01K |
| 2026-04-02 | Barbara L Brasier | Director | A | +405 | +$55.01K |
| 2026-04-02 | Richard M Schapiro | Director | A | +405 | +$55.01K |
| 2026-04-02 | Richard C Zoretic | Director | A | +405 | +$55.01K |
| 2026-04-02 | Dale B Wolf | Director | A | +405 | +$55.01K |
| 2026-04-02 | Steven J Orlando | Director | A | +405 | +$55.01K |
| 2026-04-02 | Stephen H Lockhart | Director | A | +405 | +$55.01K |
| 2026-04-02 | Leo P Grohowski | Director | A | +405 | +$55.01K |
| 2026-03-13 | Ronna Romney | Director | Sell | −506 | −$74.34K |
| 2026-03-02 | Debra Bacon | EVP, Medicaid | MIXED | +8,890 | +$1.29M |
| 2026-03-02 | Jeff D. Barlow | Chief Legal Officer | MIXED | +12,084 | +$1.75M |
| 2026-03-02 | Maurice Hebert | Chief Accounting Officer | MIXED | +2,207 | +$322.91K |
| 2026-03-02 | James Woys | Chief Operating Officer | MIXED | +15,703 | +$2.28M |
| 2026-03-02 | Mark Lowell Keim | Chief Financial Officer | MIXED | +23,765 | +$3.44M |
| 2026-03-02 | Joseph M Zubretsky | President & CEO | MIXED | +57,820 | +$8.36M |
| 2026-02-12 | Richard C Zoretic | Director | Buy | +800 | +$100.13K |
| 2026-01-02 | Debra Bacon | EVP, Medicaid | A | +22 | +$3.25K |
| 2026-01-02 | Barbara L Brasier | Director | A | +317 | +$55.01K |
| 2026-01-02 | Dale B Wolf | Director | A | +317 | +$55.01K |
| 2026-01-02 | Leo P Grohowski | Director | A | +317 | +$55.01K |
| 2026-01-02 | Richard C Zoretic | Director | A | +317 | +$55.01K |
| 2026-01-02 | Richard M Schapiro | Director | A | +317 | +$55.01K |
| 2026-01-02 | Ronna Romney | Director | A | +317 | +$55.01K |
| 2026-01-02 | Stephen H Lockhart | Director | A | +317 | +$55.01K |
| 2026-01-02 | Steven J Orlando | Director | A | +317 | +$55.01K |
| 2025-11-24 | Richard M Schapiro | Director | Sell | −357 | −$51.06K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Joseph M Zubretsky | President & CEO | 356,730 | $75.02M |
| James Woys | Chief Operating Officer | 90,178 | $18.96M |
| Mark Lowell Keim | Chief Financial Officer | 83,251 | $17.51M |
| Jeff D. Barlow | Chief Legal Officer | 67,313 | $14.16M |
| Steven J Orlando | Director | 45,750 | $9.62M |
| Ronna Romney | Director | 44,382 | $9.33M |
| Dale B Wolf | Director | 31,646 | $6.66M |
| Debra Bacon | EVP, Medicaid | 21,636 | $4.55M |
| Daniel Cooperman | Director | 14,929 | $3.14M |
| Maurice Hebert | Chief Accounting Officer | 12,815 | $2.69M |
| Richard M Schapiro | Director | 12,615 | $2.65M |
| Richard C Zoretic | Director | 9,693 | $2.04M |
| Barbara L Brasier | Director | 6,122 | $1.29M |
| Stephen H Lockhart | Director | 4,688 | $985.89K |
| Leo P Grohowski | Director | 1,846 | $388.21K |
| Francis S Soistman Jr | Director | 1,211 | $254.67K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MOH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.